Independent thinking for complex markets and current events
Alcohol consumption is down and the market is taking notice. Stocks tied to beer, wine, and spirits are falling as headlines highlight the drop in drinking. Analysts and media offer explanations everywhere. People are choosing healthier lifestyles. Prices have risen. Younger generations are less interested in alcohol. All of that may be true, but there …
Aug 26 (Reuters) – Eli Lilly (LLY.N), opens new tab said on Tuesday its experimental GLP-1 pill helped overweight adults with type 2 diabetes shed 10.5% of body weight in a late-stage trial, after recent data from another study of the drug in patients without diabetes sent company shares tumbling. Shares of the drugmaker rose …
GLP-1 weight-loss drugs are now the center of a federal crackdown. The FDA has begun seizing counterfeit semaglutide and tirzepatide products from the U.S. supply chain. Some vials contained bacterial contamination. Others were mislabeled or chemically altered. The agency confirmed more than 500 adverse event reports tied to compounded versions. Poison control centers logged nearly …
Some NHS patients could be prescribed the Wegovy weight-loss drug after limited stock arrived in the UK. The injection will be offered by some specialist NHS weight-loss management services, as well as some private clinics. As doses become available, it could help tens of thousands of patients in England, the NHS said. There has been …
by Chris Black If the drugs you’re taking are making you fat – don’t worry. We have drugs for that. Focus: US psychiatrists prescribe Wegovy to battle medication-induced weight gain https://t.co/A43fdMuKqo pic.twitter.com/xt14jKZx9B — Reuters (@Reuters) August 3, 2023